ANTICOAGULANTS

Brand Owner (click to sort) Address Description
CELLRESCUE Menarini Silicon Biosystems SpA Via Giuseppe Di Vittorio 21B/3 Castel Maggiore Bologna 40013 Italy Anticoagulants; cell preservative solutions for medical diagnostics; diagnostic preparations for medical purposes;CELL RESCUE;
CELLSECURE Johnson & Johnson One Johnson & Johnson Plaza New Brunswick NJ 08933 anticoagulants; cell preservative solutions for medical diagnostics; diagnostic preparations for medical purposes;CELL SECURE;medical diagnostic test kits comprised of cell collecting and sampling devices, cell transport vials with preservatives, and medical diagnostic reagents;
ESIPIN WUHAN QR PHARMACEUTICALS CO., LTD. MIAOSHAN PILOT, WUHAN EAST LAKE HIGH-TECH DEVELOPMENT ZONE WUHAN, HUBEI 430223 China Anticoagulants; Antifungal preparations; Cardiotonics; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the treatment and prevention of chronic heart failure; Pharmaceutical preparations for the treatment and prevention of heart failure; Pharmaceutical preparations for the treatment and prevention of idiopathic pulmonary fibrosis; Pharmaceutical preparations for the treatment and prevention of non-alcoholic steatohepatitis; Pharmaceutical preparations for the treatment and prevention of thrombosis; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical products for treating respiratory diseases and asthma;The wording Esipin has no meaning in a foreign language.;
HEPATHROM FELLOWS MEDICAL MFG. CO., INC. 1354 W. LAFAYETTE DETROIT 26 MI ANTICOAGULANTS;
HINSDAR WUHAN QR PHARMACEUTICALS CO., LTD. MIAOSHAN PILOT, WUHAN EAST LAKE HIGH-TECH DEVELOPMENT ZONE WUHAN, HUBEI 430223 China Anticoagulants; Antifungal preparations; Cardiotonics; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the treatment and prevention of chronic heart failure; Pharmaceutical preparations for the treatment and prevention of heart failure; Pharmaceutical preparations for the treatment and prevention of idiopathic pulmonary fibrosis; Pharmaceutical preparations for the treatment and prevention of non-alcoholic steatohepatitis; Pharmaceutical preparations for the treatment and prevention of thrombosis; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical products for treating respiratory diseases and asthma;The wording Hinsdar has no meaning in a foreign language.;
INDALITAN GEIGY CHEMICAL CORPORATION 89-91 BARCLAY ST. NEW YORK NY ANTICOAGULANTS;
MAXIPIN WUHAN QR PHARMACEUTICALS CO., LTD. MIAOSHAN PILOT, WUHAN EAST LAKE HIGH-TECH DEVELOPMENT ZONE WUHAN, HUBEI 430223 China Anticoagulants; Antifungal preparations; Cardiotonics; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the treatment and prevention of chronic heart failure; Pharmaceutical preparations for the treatment and prevention of heart failure; Pharmaceutical preparations for the treatment and prevention of idiopathic pulmonary fibrosis; Pharmaceutical preparations for the treatment and prevention of non-alcoholic steatohepatitis; Pharmaceutical preparations for the treatment and prevention of thrombosis; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical products for treating respiratory diseases and asthma;The wording Maxipin has no meaning in a foreign language.;
MAXIPIN WUHAN LL SCIENCE AND TECHNOLOGY DEVELOPMENT CO., LTD. BIOLAKE C2-2, NO.666 HIGH-TECH ROAD EAST LAKE HIGH-TECH DEVELOPMENT ZONE WUHAN, HUBEI 430075 China Anticoagulants; Antifungal preparations; Cardiotonics; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the treatment and prevention of chronic heart failure; Pharmaceutical preparations for the treatment and prevention of heart failure; Pharmaceutical preparations for the treatment and prevention of idiopathic pulmonary fibrosis; Pharmaceutical preparations for the treatment and prevention of non-alcoholic steatohepatitis; Pharmaceutical preparations for the treatment and prevention of thrombosis; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical products for treating respiratory diseases and asthma;The wording Maxipin has no meaning in a foreign language.;
NETONPIN WUHAN QR PHARMACEUTICALS CO., LTD. MIAOSHAN PILOT, WUHAN EAST LAKE HIGH-TECH DEVELOPMENT ZONE WUHAN, HUBEI 430223 China Anticoagulants; Antifungal preparations; Cardiotonics; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the treatment and prevention of chronic heart failure; Pharmaceutical preparations for the treatment and prevention of heart failure; Pharmaceutical preparations for the treatment and prevention of idiopathic pulmonary fibrosis; Pharmaceutical preparations for the treatment and prevention of non-alcoholic steatohepatitis; Pharmaceutical preparations for the treatment and prevention of thrombosis; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical products for treating respiratory diseases and asthma;The wording Netonpin has no meaning in a foreign language.;
PENTOSANPOLYSULFAT SP 54 bene Arzneimittel GmbH Herterichstrasse 1 D-81479 München Germany Anticoagulants, antivirals, cardiovascular pharmaceuticals, cardiovascular treatment preparations, cholesterol reducers, hemorrhoid treatment preparations, hemorrhoidal ointments, ophthalmologic preparations, pharmaceutical preparations, namely anticoagulants, pharmaceuticals, namely lipid lowering agents, suppositories;PENTOSANPOLYSULFAT;
SAFEBALM OGF 31 rue de Cambrai F-75019 Paris France Anticoagulants; antiseptics;SAFE BALM;Chemical products for use in the funeral industry, for preservation of anatomical parts and for carrying out embalming services;Funeral service undertaking; embalming services; burial services; crematorium services; conducting religious ceremonies;Medical services; hygienic care;
 

Where the owner name is not linked, that owner no longer owns the brand

   
Technical Examples
  1. The present invention provides CDR-grafted antibodies against human tissue factor that retain the high binding affinity of rodent monoclonal antibodies against tissue factor but have reduced immunogenicity. The present humanized antibodies are potent anticoagulants and are thus useful in the treatment and prophylaxis of human thrombotic disease. The invention also provides methods of making the CDR-grafted antibodies and pharmaceutical compositions for the attenuation or prevention of coagulation.